Skip to content
healthcare.dev
Get a free key

KADCYLA

NDC 50242-088, ADO-TRASTUZUMAB EMTANSINE, injection, powder, lyophilized, for solution, from Genentech, Inc..

Product NDC
50242-088
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125427
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB EMTANSINE20 mg/mL
Package NDCNDC-11Package
50242-088-01502420088011 VIAL, SINGLE-USE in 1 CARTON (50242-088-01) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/23f3c1f4-0fc8-4804-a9e3-04cf25dd302e

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-088

Use it

Look up 50242-088 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-088 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.